2021 Annual Meeting

Date: October 14-16
Location: Virtual
October 15 & 16 – Scientific & Clinical Abstract Presentations (0900-1500 CDT)
October 16 – Symposium on Epilepsy and Neoplasms (0900-1400 CDT)

Call for Abstracts

Scientific and clinical abstracts should be structured, concise, and should convey the essential findings. The abstract may not exceed 250 words. It should state the rationale, objectives, findings, and conclusions of the presentation. Finally, two to three learning objectives are required.

Preliminary Goals & Objectives
Scientific Abstract Presentations

Review of current clinical and basic science research pertaining to neuropathology with a focus on Canadian centres, but overall international participation. Also a platform for Canadian residents and trainees to present their recent work.

Diagnostic Case Presentations

Interactive discussion of rare and challenging neuropathological cases encountered by participants in their recent practice. Electronic slides and imaging results are distributed prior to meeting. Often includes case presentation by residents and illustrates advances in disease classification and diagnostic technique.

Neuropathology Practice

The lecture by Dr. Torlakovic will review quality assurance for immunohistochemical staining in neuropathology. Participants will review techniques and organizational structures to monitor and improve quality of immunohistochemical techniques. This is particularly pertinent in light of increasing numbers of immunohistochemical markers for tumor classification in neuropathology.
The panel discussion will be based on invited contributions from the participants prior to the virtual meeting. A panel of discussants, to be selected based on these questions, will address topics raised. This discussion will provide opportunity for current needs assessments and feedback on Neuropathology Practice sessions from previous years.

Jerzy Olszewski Lecture

Presentation of current clinical and research expertise in neurodegenerative disease in Saskatoon, in anticipation of next year’s venue for an in person Annual Meeting. Review concentrates on Parkinson disease and/or progressive supranuclear palsy.

Symposium on Epilepsy and Neoplasms

Program

Please check back as we will be posting the program details soon.

 

Thank you for your patience.

Invited Lecturers

Coming Soon

Trainee Awards

Mary Tom Award

Best Clinical Paper

Dr. Noor Alsafwani

Mary Tom Award

Best Clinical Paper

Winners will be Announced Soon

Morrison H. Finlayson Award

Best Basic Science

Winners will be Announced Soon

Continuing Professional Development Information

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by theCanadian Association of Neuropathologists. You may claim a maximum of 13.25 hours (credits are automatically calculated) 

Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits. Information on the process to convert Royal College MOC credit to AMA credit can be found at www.ama-assn.org/go/internationalcme

In keeping with CMA guidelines, program content and selection of speakers are the responsibility of the program committee. Support is directed towards the costs of the course and not to individual speakers. No commercial support has been solicited for this meeting.